Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines.
about
Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Novel anti-cancer drug COTI-2 ...... ce in human cancer cell lines.
@en
Novel anti-cancer drug COTI-2 ...... ce in human cancer cell lines.
@nl
type
label
Novel anti-cancer drug COTI-2 ...... ce in human cancer cell lines.
@en
Novel anti-cancer drug COTI-2 ...... ce in human cancer cell lines.
@nl
prefLabel
Novel anti-cancer drug COTI-2 ...... ce in human cancer cell lines.
@en
Novel anti-cancer drug COTI-2 ...... ce in human cancer cell lines.
@nl
P2093
P2860
P1433
P1476
Novel anti-cancer drug COTI-2 ...... ce in human cancer cell lines.
@en
P2093
James Koropatnick
Kowthar Y Salim
Saman Maleki Vareki
Wayne R Danter
P2860
P304
P356
10.1371/JOURNAL.PONE.0191766
P407
P577
2018-01-24T00:00:00Z